Rare incidence of primary adrenocortical carcinosarcoma: A case report and literature review

Wei,Yong‑Bao; Gao,Yun‑Liang; Wu,Hong‑Tao; Ou‑Yang,Shi‑Feng; Xu,Tao; Mao,Dong‑Fang; Yang,Jin‑Rui

doi:10.3892/ol.2014.2635

Rare incidence of primary adrenocortical carcinosarcoma: A case report and literature review

Authors:
- Yong‑Bao Wei
- Yun‑Liang Gao
- Hong‑Tao Wu
- Shi‑Feng Ou‑Yang
- Tao Xu
- Dong‑Fang Mao
- Jin‑Rui Yang
View Affiliations

Affiliations: Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China
Published online on: October 24, 2014 https://doi.org/10.3892/ol.2014.2635
Pages: 153-158

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adrenocortical carcinoma (ACC) is a rare, but highly aggressive type of tumor with an incidence of one to two per million annually. Adrenocortical carcinosarcoma is an exceptional variant of ACC, which is characterized by the presence of histological regions of carcinoma and sarcoma. To date, to the best of our knowledge, there have only been 12 reported cases of adrenocortical carcinosarcoma. In the present study, a case of primary, non‑functional adrenocortical carcinosarcoma is described, as well as a review of the literature to raise awareness of this particularly rare type of malignant neoplasm that is associated with a worse diagnosis and prognosis than adrenocortical carcinoma. In the present study, the patient underwent a laparoscopic left adrenalectomy and the tumor was dissected without complication from the left kidney. Microscopic observations showed the tumor comprised of epithelial and spindle cell components. The patient did not exhibit signs of tumor recurrence at the one‑month follow‑up. The potential diagnosis of adrenocortical carcinosarcoma must be considered when diagnosing adrenal malignancies in adults. In addition, comphrensive imunohistochemical staining may be required to identify possible sarcomatous patterns. To the best of our knowledge, the present case is the first to report an incidence of adrenocortical carcinosarcoma in China. Details of the patient are presented and the pathology of adrenocortical carcinosarcoma is discussed.

View Figures

View References

1	Lacroix A: Approach to the patient with adrenocortical carcinoma. J Clin Endocrinol Metab. 95:4812–4822. 2010. View Article : Google Scholar : PubMed/NCBI
2	Zini L, Porpiglia F and Fassnacht M: Contemporary management of adrenocortical carcinoma. Eur Urol. 60:1055–1065. 2011. View Article : Google Scholar : PubMed/NCBI
3	Fassnacht M, Libé R, Kroiss M and Allolio B: Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol. 7:323–335. 2011. View Article : Google Scholar : PubMed/NCBI
4	Ng L and Libertino JM: Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol. 169:5–11. 2003. View Article : Google Scholar
5	Roman S: Adrenocortical carcinoma. Curr Opin Oncol. 18:36–42. 2006. View Article : Google Scholar
6	Crucitti F, Bellantone R, Ferrante A, et al: The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery. 119:161–170. 1996. View Article : Google Scholar : PubMed/NCBI
7	Icard P, Goudet P, Charpenay C, et al: Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg. 25:891–897. 2001. View Article : Google Scholar : PubMed/NCBI
8	Tauchmanovà L, Colao A, Marzano LA, et al: Andrenocortical carcinomas: twelve-year prospective experience. World J Surg. 28:896–903. 2004. View Article : Google Scholar : PubMed/NCBI
9	Decorato JW, Gruber H, Petti M and Levowitz BS: Adrenal carcinosarcoma. J Surg Oncol. 45:134–136. 1990. View Article : Google Scholar : PubMed/NCBI
10	Fischler DF, Nunez C, Levin HS, et al: Adrenal carcinosarcoma presenting in a woman with clinical signs of virilization. A case report with immunohistochemical and ultrastructural findings. Am J Surg Pathol. 16:626–631. 1992. View Article : Google Scholar : PubMed/NCBI
11	Sasaki K, Desimone M, Rao HR, et al: Adrenocortical carcinosarcoma: a case report and review of the literature. Diagn Pathol. 5:512010.PubMed/NCBI
12	Thway K, Olmos D, Shah C, et al: Oncocytic adrenal cortical carcinosarcoma with pleomorphic rhabdomyosarcomatous metastases. Am J Surg Pathol. 36:470–477. 2012. View Article : Google Scholar : PubMed/NCBI
13	Barksdale SK, Marincola FM and Jaffe G: Carcinosarcoma of the adrenal cortex presenting with mineralocorticoid excess. Am J Surg Pathol. 17:941–945. 1993. View Article : Google Scholar : PubMed/NCBI
14	Okazumi S, Asano T, Ryu M, et al: Surgical resection of adrenal carcinoma extending into the vena cava, right atrium and ventricle: case report and review of the literature. Nihon Geka Gakkai Zasshi. 88:231–238. 1987.(In Japanese). PubMed/NCBI
15	Collina G, Maldarizzi F, Betts CM and Eusebi V: Primary sarcomatoid carcinoma of the adrenal gland. First case report. Virchows Arch A Pathol Anat Histopathol. 415:161–167. 1989. View Article : Google Scholar : PubMed/NCBI
16	Lee MS, Park IA, Chi JG, et al: Adrenal carcinosarcoma - a case report. J Korean Med Sci. 12:374–377. 1997. View Article : Google Scholar : PubMed/NCBI
17	Sturm N, Moulai N, Laverrière MH, et al: Primary adrenocortical sarcomatoid carcinoma: case report and review of literature. Virchows Arch. 452:215–219. 2008. View Article : Google Scholar
18	Coli A, Di Giorgio A, Castri F, et al: Sarcomatoid carcinoma of the adrenal gland: a case report and review of literature. Pathol Res Pract. 206:59–65. 2010. View Article : Google Scholar
19	Bertolini F, Rossi G, Fiocchi F, et al: Primary adrenal gland carcinosarcoma associated with metastatic rectal cancer: a hitherto unreported collision tumor. Tumori. 97:27e–30e. 2011.PubMed/NCBI
20	Kao CS, Grignon DJ, Ulbright TM and Idrees MT: A case report of adrenocortical carcinosarcoma with oncocytic and primitive neuroectodermal-like features. Hum pathol. 44:1947–1955. 2013. View Article : Google Scholar : PubMed/NCBI
21	Miettinen M: Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy. Lab Invest. 66:169–174. 1992.PubMed/NCBI
22	Hoang MP, Ayala AG and Albores-Saavedra J: Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol. 15:973–978. 2002. View Article : Google Scholar : PubMed/NCBI
23	Jorda M, De MB and Nadji M: Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas. Appl Immunohistochem Mol Morphol. 10:67–70. 2002. View Article : Google Scholar : PubMed/NCBI
24	Ghorab Z, Jorda M, Ganjei P and Nadji M: Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas. Appl Immunohistochem Mol Morphol. 11:330–333. 2003. View Article : Google Scholar : PubMed/NCBI
25	Zhang PJ, Genega EM, Tomaszewski JE, et al: The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol. 16:591–597. 2003. View Article : Google Scholar : PubMed/NCBI
26	Pan CC, Chen PC, Tsay SH and Ho DM: Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique. Appl Immunohistochem Mol Morphol. 13:347–352. 2005. View Article : Google Scholar : PubMed/NCBI